Developmental Care for Congenital Heart Defects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to care for newborns with congenital heart defects (CHD) to determine if it can improve their development and health outcomes. The focus is on using individualized developmental care (IDC) in the hospital to reduce stress from treatments and help both infants and their parents cope better. In this trial, one group of infants will receive this special care, known as NIDCAP Developmental Care, while another group will receive standard hospital care. Good candidates for this study are newborns at Boston Children's Hospital with complex CHD requiring early heart surgery, who are free from other major health issues and have access to a phone or the internet. As an unphased trial, this study offers a unique opportunity to contribute to innovative care strategies for newborns with CHD.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this developmental care intervention is safe for infants with congenital heart disease?
Research has shown that the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) is safe and well-tolerated. Studies indicate that NIDCAP improves outcomes for premature babies by supporting brain development, enhancing thinking skills, and improving behavior without causing harm. These findings suggest that NIDCAP is safe for infants.
In this trial, researchers are testing NIDCAP for babies with congenital heart defects. Although this application is new for these patients, the positive safety record in other infant groups is encouraging. NIDCAP aims to reduce stress and create a calming hospital environment. This approach is designed to support healthy development, making it a low-risk option.12345Why are researchers excited about this trial?
Researchers are excited about the NIDCAP developmental care for congenital heart defects because it offers a unique approach to supporting infants with these conditions. Unlike standard medical treatments that focus primarily on surgical or pharmaceutical interventions, NIDCAP emphasizes individualized care tailored to each infant's developmental needs. This approach aims to create a nurturing environment that supports brain development and enhances long-term outcomes. By focusing on personalized, sensitive care, NIDCAP could potentially improve cognitive and emotional development in ways that traditional medical treatments do not address.
What evidence suggests that this developmental care is effective for congenital heart defects?
Research shows that the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) can greatly help babies in intensive care. Studies have found that babies receiving NIDCAP often experience better health outcomes, such as reduced time on breathing machines and easier weight gain. Evidence also suggests these babies may spend less time in the hospital. While most research has focused on premature babies, the positive results indicate potential benefits for babies with congenital heart defects (CHD) as well. In this trial, some participants will receive NIDCAP developmental care, while others will receive standard care. By reducing stress and supporting growth, NIDCAP may improve both the health and development of these babies over time.13678
Who Is on the Research Team?
Samantha Butler, PhD
Principal Investigator
Boston Children's Hospital
Are You a Good Fit for This Trial?
This trial is for newborns with complex congenital heart disease admitted to Boston Children's Hospital within 3 days of birth, needing open-heart surgery within two weeks. Eligible infants must be full-term, have no prior cardiac surgeries or severe associated anomalies, and not exposed to maternal substances. Mothers should be aged 20-45 years without known chromosomal abnormalities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Infants receive Individualized Developmental Care (IDC) following the NIDCAP model in the Cardiac Intensive Care Unit (CICU) and Acute Cardiology Care Unit (ACCU).
Follow-up
Participants are monitored for developmental outcomes and parent engagement after discharge.
What Are the Treatments Tested in This Trial?
Interventions
- NIDCAP Developmental Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor